Skip to main content
Clinical Trials/CTRI/2023/05/052389
CTRI/2023/05/052389Not yet recruitingPhase 3

Evaluation of comparative efficacy of Kshar Basti & Kanchanar Guggulu versus Levothyroxine in the treatment of Hypothyroidism

Satyajit Pandurang Kulkarni PhD student self finance0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1.Age range â?? 20 â?? 60 years
  • 2.Sex â?? either
  • 3.Known case of Hypothyroidism or newly diagnosed case of hypothyroidism
  • 4.Serum TSH levels range 5.0 mIU/ml â?? 30 mIU/ml or as defined by ICD

Exclusion Criteria

  • 1.Acute hypothyroidism
  • 2. Chronic hypothyroidism associated with DM, HTN, malignancy, heart disease, liver disease, or gynecological disorders.
  • 3. pregnancy, lactating women, contraceptive pills
  • 4. depression or any co-existing psychiatric condition
  • 4. Basti contra-indications

Investigators

Sponsor
Satyajit Pandurang Kulkarni PhD student self finance

Similar Trials